Good quarter but muted outlook. Novelis' adjusted EBITDA of US$240 mn was 5% ahead of our estimates. EBITDA performance was aided by operational/cost efficiencies. We expect a muted FY2014 performance due to regional pricing and general costs pressures amid low volume growth. High working capital requirement and capex spend could further stretch consolidated leverage.
Retain REDUCE.
